Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
44.32 USD | -0.88% | -3.15% | +25.97% |
Jun. 04 | Oppenheimer Raises Price Target on Crinetics Pharmaceuticals to $74 From $55, Maintains Outperform Rating | MT |
Jun. 03 | Transcript : Crinetics Pharmaceuticals, Inc. - Special Call |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+25.97% | 3.53B | |
+46.01% | 57.87B | |
+40.74% | 40.25B | |
-6.91% | 39.94B | |
-5.16% | 28.54B | |
+11.02% | 26.4B | |
-20.77% | 19.33B | |
+29.66% | 12.4B | |
-1.45% | 12.23B | |
+23.32% | 12.2B |
- Stock Market
- Equities
- CRNX Stock
- News Crinetics Pharmaceuticals, Inc.
- HC Wainwright Raises Crinetics Pharmaceuticals Price Target to $60 From $50, Maintains Buy Rating